Labcorp Holdings Inc. Files 8-K

TL;DR

Labcorp filed an 8-K on 12/30/25 with corporate info and exhibits.

AI Summary

Labcorp Holdings Inc. filed an 8-K on December 30, 2025, reporting information under Regulation FD and including financial statements and exhibits. The filing details the company's principal executive offices located at 358 South Main Street, Burlington, North Carolina, 27215, with a business phone number of 336-229-1127. The company was incorporated in Delaware and previously operated under the names Laboratory Corp of America Holdings and National Health Laboratories Holdings Inc.

Why It Matters

This 8-K filing provides an update on Labcorp's corporate information and regulatory disclosures, which is important for investors and stakeholders to stay informed about the company's official reporting.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not contain information that suggests immediate financial or operational risk.

Key Players & Entities

• LABCORP HOLDINGS INC. (company) — Registrant
• 358 South Main Street, Burlington, North Carolina, 27215 (location) — Principal executive offices
• 336-229-1127 (phone_number) — Business phone number
• Laboratory Corp of America Holdings (company) — Former company name
• National Health Laboratories Holdings Inc (company) — Former company name

FAQ

From the Filing

0000920148-25-000125.txt : 20251230 0000920148-25-000125.hdr.sgml : 20251230 20251230161708 ACCESSION NUMBER: 0000920148-25-000125 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20251230 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251230 DATE AS OF CHANGE: 20251230 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABCORP HOLDINGS INC. CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 992588107 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 251614474 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS DATE OF NAME CHANGE: 19950504 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 8-K 1 lh-20251230.htm 8-K lh-20251230 0000920148 false 0000920148 2025-12-30 2025-12-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.  20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 December 30, 2025 (Date of earliest event reported) LABCORP HOLDINGS INC. (Exact Name of Registrant as Specified in its Charter) Delaware   1-11353   99-2588107 (State or other jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.) 358 South Main Street   Burlington , North Carolina 27215 (Address of principal executive offices) (Zip Code) (Registrant’s telephone number including area code) 336 - 229-1127 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of exchange on which registered Common Stock, $0.10 par value LH New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).              Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 7.01 Regulation FD Disclosure Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced on December 30, 2025, that the Company will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 at 4:30 p.m. (PT). A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein. A live audio webcast of the fireside chat will be available via the Company Investor Relations website at ir.Labcorp.com and archived for replay. Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press Release dated December 30 , 2025 issued by Labcorp Holdings Inc. Exhibit 104 Co